Multi-Omic Data Interpretation to Repurpose Subtype Specific Drug Candidates for Breast Cancer

MLA

Beste Turanli, et al. Multi-Omic Data Interpretation to Repurpose Subtype Specific Drug Candidates for Breast Cancer. May 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0925d5359dc28e6c5374d9139f0f5b82&authtype=sso&custid=ns315887.

APA

Beste Turanli, Kubra Karagoz, Gholamreza Bidkhori, Raghu Sinha, Michael L. Gatza, Mathias Uhlen, Adil Mardinoglu, & Kazim Yalcin Arga. (2019). Multi-Omic Data Interpretation to Repurpose Subtype Specific Drug Candidates for Breast Cancer.

Chicago

Beste Turanli, Kubra Karagoz, Gholamreza Bidkhori, Raghu Sinha, Michael L. Gatza, Mathias Uhlen, Adil Mardinoglu, and Kazim Yalcin Arga. 2019. “Multi-Omic Data Interpretation to Repurpose Subtype Specific Drug Candidates for Breast Cancer,” May. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0925d5359dc28e6c5374d9139f0f5b82&authtype=sso&custid=ns315887.